Understanding Type 2 Inflammation

In this video interview, Marc Serota, MD, discusses his research regarding type 2 inflammation, the future of treating it as 1 condition or 2, and why physicians should educate their patients about this type of inflammation.

Related Videos
Related Content

Investigational LEO Pharma IL-22 Receptor Improves EASI Scores in AD

March 27th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants

March 23rd 2023

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Investigational LEO Pharma IL-22 Receptor Improves EASI Scores in AD

March 27th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants

March 23rd 2023

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023

Investigational LEO Pharma IL-22 Receptor Improves EASI Scores in AD

March 27th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis

March 24th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants

March 23rd 2023

Pregnant Women with Skin Conditions May Require Dermatologic Intervention

March 23rd 2023
© 2023 MJH Life Sciences

All rights reserved.